Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Epilepsy & Behavior

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.yebeh.2016.10.007PMID 28038393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial

  2016cited by this paper
• Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

  2016cited by this paper
• Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression.

  2016cited by this paper
• Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression.

  2016cited by this paper
• Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites

  2016cited by this paper
• Management of psychiatric and neurological comorbidities in epilepsy

  2016cited by this paper
• Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes

  2015cited by this paper
• Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response.

  2015cited by this paper
• The importance of cytokines and autoantibodies in depression.

  2015cited by this paper
• Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy.

  2015cited by this paper
• Breakthrough Seizures after Starting Vilazodone for Depression

  2015cited by this paper
• A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression.

  2015cited by this paper
• Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial

  2015cited by this paper
• Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.

  2015cited by this paper
• Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour.

  2014cited by this paper
• Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta‐analysis of randomized placebo‐controlled trials

  2014cited by this paper
• Ficus religiosa L. figs--a potential herbal adjuvant to phenytoin for improved management of epilepsy and associated behavioral comorbidities.

  2014cited by this paper
• Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis.

  2014cited by this paper
• Antidepressant-like effect of celecoxib piroxicam in rat models of depression

  2014cited by this paper
• Kynurenines in CNS disease: regulation by inflammatory cytokines

  2014cited by this paper
• Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy

  2014cited by this paper
• Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral Tests

  2014cited by this paper
• Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells

  2013cited by this paper
• Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved

  2013cited by this paper
• The effects of native whey and α-lactalbumin on the social and individual behaviour of C57BL/6J mice.

  2013cited by this paper
• Upregulation of the dorsal raphe nucleus-prefrontal cortex serotonin system by chronic treatment with escitalopram in hyposerotonergic Wistar-Kyoto rats.

  2013cited by this paper
• Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice.

  2013cited by this paper
• New avenues for anti-epileptic drug discovery and development

  2013cited by this paper
• Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

  2012cited by this paper
• Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis

  2012cited by this paper
• Kynurenines in the CNS: recent advances and new questions

  2012cited by this paper
• Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

  2012cited by this paper
• Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression.

  2012cited by this paper
• Minocycline: therapeutic potential in psychiatry.

  2012cited by this paper
• The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy

  2012cited by this paper
• The Kynurenine Pathway

  2012cited by this paper
• Depression, stress, epilepsy and adult neurogenesis.

  2012cited by this paper
• Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression

  2012cited by this paper
• Preclinical antiepileptic actions of selective serotonin reuptake inhibitors—Implications for clinical trial design

  2012cited by this paper
• One-year seizure prognosis in epilepsy patients treated with antidepressants.

  2011cited by this paper
• Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus

  2011cited by this paper
• Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits

  2011cited by this paper
• COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.

  2010cited by this paper
• Comorbidity between epilepsy and depression: Experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms

  2010cited by this paper
• Enhanced IL‐1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice

  2010cited by this paper
• Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis.

  2010cited by this paper
• Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

  2010cited by this paper
• Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

  2009cited by this paper
• Induction of IDO by Bacille Calmette-Guérin Is Responsible for Development of Murine Depressive-Like Behavior1

  2009cited by this paper
• Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.

  2009cited by this paper
• L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications

  2009cited by this paper
• The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells

  2009cited by this paper
• Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease

  2009cited by this paper
• Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.

  2008cited by this paper
• Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

  2008cited by this paper
• IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress

  2008cited by this paper
• Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides.

  2008cited by this paper
• Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5-hydroxyindole acetic acid levels

  2008cited by this paper
• The neurobehavioural comorbidities of epilepsy: can a natural history be developed?

  2008cited by this paper
• Does minocycline have antidepressant effect?

  2008cited by this paper
• Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.

  2008cited by this paper
• Dietary Amino Acids and Brain Serotonin Function; Implications for Stress-Related Affective Changes

  2008cited by this paper
• Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

  2008cited by this paper
• Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction.

  2007cited by this paper
• Which clinical and experimental data link temporal lobe epilepsy with depression?

  2007cited by this paper
• Effect of the COX-2 Inhibitor Celecoxib on Behavioural and Immune Changes in an Olfactory Bulbectomised Rat Model of Depression

  2007cited by this paper
• Important messages in the 'post': recent discoveries in 5-HT neurone feedback control.

  2007cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

  2006cited by this paper
• Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system.

  2006cited by this paper
• The effects of a diet enriched with α-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls

  2005cited by this paper
• Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists.

  2005cited by this paper
• Citalopram as Treatment of Depression in Patients With Epilepsy

  2004cited by this paper
• In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors.

  2004cited by this paper
• Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia.

  2004cited by this paper
• Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis.

  2003cited by this paper
• Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.

  2003cited by this paper
• The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis.

  2003cited by this paper
• Effect of rofecoxib on nociception and the serotonin system in the rat brain

  2002cited by this paper
• Inhibition of COX‐2 reduces the age‐dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat

  2002cited by this paper
• Effects of Fluoxetine and TFMPP on Spontaneous Seizures in Rats with Pilocarpine‐induced Epilepsy

  2002cited by this paper
• Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy.

  2002cited by this paper
• The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress.

  2000cited by this paper
• Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy

  2000cited by this paper
• Clinical and Physiological Consequences of Rapid Tryptophan Depletion

  2000cited by this paper
• Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices.

  2000cited by this paper
• The Use of Sertraline in Patients with Epilepsy: Is It Safe?

  2000cited by this paper
• Treatment of Interictal Depression with Citalopram in Patients with Epilepsy.

  2000cited by this paper
• Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity

  1998cited by this paper
• α‐Lactalbumin‐enriched low‐protein infant formulas: a comparison to breast milk feeding

  1996cited by this paper
• Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain

  1996cited by this paper
• Anticonvulsant effect of fluoxetine in humans

  1995cited by this paper
• The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat.

  1995cited by this paper
• Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy.

  1994cited by this paper
• Fluvoxamine: an antidepressant with low (or no) epileptogenic effect.

  1990cited by this paper
• Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.

  1988cited by this paper
• Indoleamine 2,3-dioxygenase. Purification and some properties.

  1978cited by this paper

• Serotonin Receptors as a Potential Therapeutic Target in Epilepsy

  2025cites this paper
• Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia

  2024cites this paper
• Reconnoitering the transformative journey of minocycline from an antibiotic to an antiepileptic drug.

  2022cites this paper
• Therapeutic potential of selective serotonin reuptake inhibitor and anti-inflammatory COX-2 inhibitors drugs for epilepsy

  2022influential citation
• Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand?

  2022cites this paper
• Kynurenine Metabolism and Alzheimer’s Disease: The Potential Targets and Approaches

  2022cites this paper
• Chronically altered NMDAR signaling in epilepsy mediates comorbid depression

  2021cites this paper
• Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities

  2021cites this paper
• Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy

  2021cites this paper
• PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability

  2021cites this paper
• Anticonvulsant Effect of Asparagus racemosus Willd. in a Mouse Model of Catamenial Epilepsy

  2021cites this paper
• Ferulic acid inhibits catamenial epilepsy through modulation of female hormones

  2021cites this paper
• Depression and Quality of Life in Patients with Epilepsy - Single Centre Experience.

  2021cites this paper
• Intraperitoneal injection of lipopolysaccharide prevents seizure‐induced respiratory arrest in a DBA/1 mouse model of SUDEP

  2020cites this paper
• Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives

  2019cites this paper
• Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives

  2019cites this paper
• Clinician Liability in Prescribing Antidepressants.

  2019cites this paper
• Current and emerging drug therapies for the treatment of depression in adults with epilepsy

  2018cites this paper
• HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy

  2018cites this paper
• HBK-14 and HBK-15, triple 5-HT1A, 5-HT7 and 5-HT3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in mice.

  2017cites this paper
• Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals.

  2017cites this paper
• Antidepressants in people with epilepsy: A double-edge sword!

  2017cites this paper
• Ferulic Acid Supplementation for Management of Depression in Epilepsy

  2017cites this paper